After further investigation, we found that EGFR phosphorylation could affect the activation of the mTOR/Akt signaling pathway, and regulation of CDT1-, cyclin D1-, and p21-related cell cycle modulation could be the potential mechanism of ACACB in CRC. The gene discussed is AKT1; the disease is colorectal carcinoma.